ID

16292

Descrizione

Neoadjuvant GW572016 to Treat Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00206427

collegamento

https://clinicaltrials.gov/show/NCT00206427

Keywords

versioni (1)
  1. 10/07/16 10/07/16 -
Caricato su

10 luglio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT00206427

Inglese

Eligibility Breast Cancer NCT00206427

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. all patients must be female.
Descrizione

Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
2. signed informed consent.
Descrizione

Informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
3. locally advanced breast cancers or primary breast cancers with concomitant gross metastatic disease are eligible. locally advanced cancers must be of clinical and/or radiologic size >/- 5 cm, and/or are deemed surgically inoperable, with stage iiib, iiic, or iv disease.
Descrizione

Locally advanced breast cancer | malignant neoplasm of breast TNM staging primary tumor | Metastatic Neoplasm Gross | Locally Advanced Malignant Neoplasm size | Locally Advanced Malignant Neoplasm Inoperable | TNM clinical staging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2]
C2216708
UMLS CUI [3,1]
C2939420
UMLS CUI [3,2]
C0439806
UMLS CUI [4,1]
C0677984
UMLS CUI [4,2]
C0456389
UMLS CUI [5,1]
C0677984
UMLS CUI [5,2]
C0205187
UMLS CUI [6]
C3258246
4. her2 overexpressing tumors defined as herceptest score of 3+, or >/- 10% cells moderately or strongly her2 positive by other methods, or semi-quantitative score of >/- 5 (in dr. allred's laboratory) or gene amplified.
Descrizione

HER2-positive carcinoma of breast | Score | HER2-positive carcinoma of breast Moderate | HER2-positive carcinoma of breast Strong | Allred score Semi-quantitative | Gene Amplification

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1960398
UMLS CUI [2]
C0449820
UMLS CUI [3,1]
C1960398
UMLS CUI [3,2]
C0205081
UMLS CUI [4,1]
C1960398
UMLS CUI [4,2]
C0442821
UMLS CUI [5,1]
C2919519
UMLS CUI [5,2]
C0522525
UMLS CUI [6]
C0017256
5. negative serum pregnancy test (bhcg) within 7 days of starting study, if of child-bearing potential.
Descrizione

Childbearing Potential Serum pregnancy test negative | Chorionic Gonadotropin, beta Subunit, Human

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
UMLS CUI [2]
C0106132
6. kidney and liver function tests - all within 1.5 times the institution's upper limit of normal.
Descrizione

Kidney Function Tests | Liver Function Tests

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022662
UMLS CUI [2]
C0023901
7. performance status (who scale) less than 2 and life expectancy greater than 6 months.
Descrizione

WHO performance status scale | Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1298650
UMLS CUI [2]
C0023671
8. age greater than 18 years.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
9. no brain or leptomeningeal disease.
Descrizione

Brain Diseases | Leptomeningeal disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006111
UMLS CUI [2]
C3160796
10. no previous or current malignancies at other sites within the last 5 years, with exception of adequately treated core-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
Descrizione

Malignant Neoplasms Site | Therapeutic procedure Core biopsy Carcinoma in situ of uterine cervix | Therapeutic procedure Core biopsy Basal cell carcinoma | Therapeutic procedure Core biopsy Squamous cell carcinoma of skin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1515974
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1318309
UMLS CUI [2,3]
C0851140
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1318309
UMLS CUI [3,3]
C0007117
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C1318309
UMLS CUI [4,3]
C0553723
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential.
Descrizione

Pregnancy | Childbearing Potential Contraceptive methods Unwilling

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0558080
2. severe underlying chronic illness or disease.
Descrizione

Chronic disease Severe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0205082
3. cardiomyopathy or baseline lvef <50%.
Descrizione

Cardiomyopathies | Left ventricular ejection fraction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0878544
UMLS CUI [2]
C0428772
4. other investigational drugs while on study.
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
5. severe or uncontrolled hypertension, history of congestive heart failure or severe coronary arterial disease.
Descrizione

Hypertension, severe | Uncontrolled hypertension | Congestive heart failure | Coronary heart disease Severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2]
C1868885
UMLS CUI [3]
C0018802
UMLS CUI [4,1]
C0010068
UMLS CUI [4,2]
C0205082
6. malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel. subjects with ulcerative colitis are also excluded.
Descrizione

Malabsorption Syndrome | Disease Affecting gastrointestinal function | Gastrectomy | Small intestine excision | Ulcerative Colitis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0024523
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0516983
UMLS CUI [3]
C0017118
UMLS CUI [4]
C0192601
UMLS CUI [5]
C0009324
7. taking any gw572016-prohibited medication (see gw572016 prohibited medications list in protocol) within 7 days of first dose of study medications.
Descrizione

GW572016 Illicit Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1384663
UMLS CUI [1,2]
C0086190
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT00206427

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
1. all patients must be female.
boolean
C0079399 (UMLS CUI [1])
Informed consent
Item
2. signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Locally advanced breast cancer | malignant neoplasm of breast TNM staging primary tumor | Metastatic Neoplasm Gross | Locally Advanced Malignant Neoplasm size | Locally Advanced Malignant Neoplasm Inoperable | TNM clinical staging
Item
3. locally advanced breast cancers or primary breast cancers with concomitant gross metastatic disease are eligible. locally advanced cancers must be of clinical and/or radiologic size >/- 5 cm, and/or are deemed surgically inoperable, with stage iiib, iiic, or iv disease.
boolean
C3495949 (UMLS CUI [1])
C2216708 (UMLS CUI [2])
C2939420 (UMLS CUI [3,1])
C0439806 (UMLS CUI [3,2])
C0677984 (UMLS CUI [4,1])
C0456389 (UMLS CUI [4,2])
C0677984 (UMLS CUI [5,1])
C0205187 (UMLS CUI [5,2])
C3258246 (UMLS CUI [6])
HER2-positive carcinoma of breast | Score | HER2-positive carcinoma of breast Moderate | HER2-positive carcinoma of breast Strong | Allred score Semi-quantitative | Gene Amplification
Item
4. her2 overexpressing tumors defined as herceptest score of 3+, or >/- 10% cells moderately or strongly her2 positive by other methods, or semi-quantitative score of >/- 5 (in dr. allred's laboratory) or gene amplified.
boolean
C1960398 (UMLS CUI [1])
C0449820 (UMLS CUI [2])
C1960398 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C1960398 (UMLS CUI [4,1])
C0442821 (UMLS CUI [4,2])
C2919519 (UMLS CUI [5,1])
C0522525 (UMLS CUI [5,2])
C0017256 (UMLS CUI [6])
Childbearing Potential Serum pregnancy test negative | Chorionic Gonadotropin, beta Subunit, Human
Item
5. negative serum pregnancy test (bhcg) within 7 days of starting study, if of child-bearing potential.
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C0106132 (UMLS CUI [2])
Kidney Function Tests | Liver Function Tests
Item
6. kidney and liver function tests - all within 1.5 times the institution's upper limit of normal.
boolean
C0022662 (UMLS CUI [1])
C0023901 (UMLS CUI [2])
WHO performance status scale | Life Expectancy
Item
7. performance status (who scale) less than 2 and life expectancy greater than 6 months.
boolean
C1298650 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Age
Item
8. age greater than 18 years.
boolean
C0001779 (UMLS CUI [1])
Brain Diseases | Leptomeningeal disease
Item
9. no brain or leptomeningeal disease.
boolean
C0006111 (UMLS CUI [1])
C3160796 (UMLS CUI [2])
Malignant Neoplasms Site | Therapeutic procedure Core biopsy Carcinoma in situ of uterine cervix | Therapeutic procedure Core biopsy Basal cell carcinoma | Therapeutic procedure Core biopsy Squamous cell carcinoma of skin
Item
10. no previous or current malignancies at other sites within the last 5 years, with exception of adequately treated core-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1318309 (UMLS CUI [2,2])
C0851140 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C1318309 (UMLS CUI [3,2])
C0007117 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C1318309 (UMLS CUI [4,2])
C0553723 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Childbearing Potential Contraceptive methods Unwilling
Item
1. pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential.
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Chronic disease Severe
Item
2. severe underlying chronic illness or disease.
boolean
C0008679 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Cardiomyopathies | Left ventricular ejection fraction
Item
3. cardiomyopathy or baseline lvef <50%.
boolean
C0878544 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
Investigational New Drugs
Item
4. other investigational drugs while on study.
boolean
C0013230 (UMLS CUI [1])
Hypertension, severe | Uncontrolled hypertension | Congestive heart failure | Coronary heart disease Severe
Item
5. severe or uncontrolled hypertension, history of congestive heart failure or severe coronary arterial disease.
boolean
C4013784 (UMLS CUI [1])
C1868885 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
C0010068 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
Malabsorption Syndrome | Disease Affecting gastrointestinal function | Gastrectomy | Small intestine excision | Ulcerative Colitis
Item
6. malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel. subjects with ulcerative colitis are also excluded.
boolean
C0024523 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0516983 (UMLS CUI [2,3])
C0017118 (UMLS CUI [3])
C0192601 (UMLS CUI [4])
C0009324 (UMLS CUI [5])
GW572016 Illicit Drugs
Item
7. taking any gw572016-prohibited medication (see gw572016 prohibited medications list in protocol) within 7 days of first dose of study medications.
boolean
C1384663 (UMLS CUI [1,1])
C0086190 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial